Cardiac repair with injectable cell sheet fragments of human amniotic fluid stem cells in an immune-suppressed rat model

Biomaterials

Volumn 31, Issue 25, 2010, Pages 6444-6453

  Yeh, Yi Chun ^a   Lee, Wen Yu ^a   Yu, Chu Leng ^b   Hwang, Shiaw Min ^c   Chung, Min Fan ^a   Hsu, Li Wen ^a   Chang, Yen ^b   Lin, Wei Wen ^d   Tsai, Ming Song ^e   Wei, Hao Ji ^b   Sung, Hsing Wen ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c FOOD INDUSTRY RESEARCH AND DEVELOPMENT INSTITUTE   (Taiwan)

^d TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e CATHAY GENERAL HOSPITAL   (Taiwan)

Author keywords

Angiogenesis; Cardiomyogenesis; Cell transplantation; Myocardial infarction; Thermo responsive hydrogel

Indexed keywords

ANGIOGENESIS; CARDIOMYOGENESIS; CELL TRANSPLANTATION; MYOCARDIAL INFARCTION; THERMO-RESPONSIVE; THERMO-RESPONSIVE HYDROGEL;

BIOMATERIALS; CYTOLOGY; ECHOCARDIOGRAPHY; ENDOTHELIAL CELLS; HYDROGELS; POLYMERASE CHAIN REACTION;

STEM CELLS;

FIBRONECTIN; LAMININ; METHYLCELLULOSE; VIMENTIN; VITRONECTIN; HYDROGEL;

AMNION FLUID; AMNIOTIC FLUID STEM CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTERIOLE DENSITY; ARTICLE; CAPILLARY DENSITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE WALL; HEART MUSCLE; HYDROGEL; IMMUNE DEFICIENCY; M MODE ECHOCARDIOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RAT; SECOND TRIMESTER PREGNANCY; STEM CELL; STEM CELL TRANSPLANTATION; TREATMENT RESPONSE; XENOGRAFT; ANGIOGENESIS; ANIMAL; CHEMISTRY; CYTOLOGY; HEART; HEART MUSCLE CELL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INJECTION; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES;

AMNIOTIC FLUID; ANIMALS; HEART; HUMANS; HYDROGEL; IMMUNOSUPPRESSION; INJECTIONS; METHYLCELLULOSE; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; STEM CELL TRANSPLANTATION; STEM CELLS;

RATTUS;

EID: 77953960139     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.04.069     Document Type: Article

References (38)

1. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410:701-705.
2. Ryu J.H., Kim I.K., Cho S.W., Cho M.C., Hwang K.K., Piao H., et al. Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardium. Biomaterials 2005, 26:319-326.
3. Perin E.C., Dohmann H.F., Borojevic R., Silva S.A., Sousa A.L., Mesquita C.T., et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003, 107:2294-2302.
4. Reffelmann T., Könemann S., Kloner R.A. Promise of blood- and bone marrow-derived stem cell transplantation for functional cardiac repair: putting it in perspective with existing therapy. J Am Coll Cardiol 2009, 53:305-308.
5. Wolbank S., Stadler G., Peterbauer A., Gillich A., Karbiener M., Streubel B., et al. Telomerase immortalized human amnion- and adipose-derived mesenchymal stem cells: maintenance of differentiation and immunomodulatory characteristics. Tissue Eng Part A 2009, 15:1843-1854.
6. De Coppi P., Bartsch G., Siddiqui M.M., Xu T., Santos C.C., Perin L., et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007, 25:100-106.
7. Yeh Y.C., Wei H.J., Lee W.Y., Yu C.L., Chang Y., Hsu L.W., et al. Cellular cardiomyoplasty with human amniotic fluid stem cells: in vitro and in vivo studies. Tissue Eng Part A 2010, [Online], Available from, [Accessed 24.02.10]. 10.1089/ten.tea.2009.0728.
8. Freshney R.I. Culture of animal cells: a manual of basic technique 1994, Wiley-Liss, New York. 3rd ed.
9. Memon I.A., Sawa Y., Fukushima N., Matsumiya G., Miyagawa S., Taketani S., et al. Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets. J Thorac Cardiovasc Surg 2005, 130:1333-1341.
10. Teng C.J., Luo J., Chiu R.C., Shum-Tim D. Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: Implications for cellular cardiomyoplasty. J Thorac Cardiovasc Surg 2006, 132:628-632.
11. Chen C.H., Chang Y., Wang C.C., Huang C.H., Huang C.C., Yeh Y.C., et al. Construction and characterization of fragmented mesenchymal-stem-cell sheets for intramuscular injection. Biomaterials 2007, 28:4634-4651.
12. Tsai M.S., Hwang S.M., Tsai Y.L., Cheng F.C., Lee J.L., Chang Y.J. Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells. Biol Reprod 2006, 74:545-551.
13. Chen C.H., Tsai C.C., Chen W., Mi F.L., Liang H.F., Chen S.C., et al. Novel living cell sheet harvest system composed of thermoreversible methylcellulose hydrogels. Biomacromolecules 2006, 7:736-743.
14. Neff J.A., Tresco P.A., Caldwell K.D. Surface modification for controlled studies of cell-ligand interactions. Biomaterials 1999, 20:2377-2393.
15. Matsubayashi K., Fedak P.W., Mickle D.A., Weisel R.D., Ozawa T., Li R.K. Improved left ventricular aneurysm repair with bioengineered vascular smooth muscle grafts. Circulation 2003, 108(Suppl. 1):II219-II225.
16. Caspi O., Huber I., Kehat I., Habib M., Arbel G., Gepstein A., et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol 2007, 50:1884-1893.
17. Gandia C., Armiñan A., García-Verdugo J.M., Lledó E., Ruiz A., Miñana M.D., et al. Human dental pulp stem cells improve left ventricular function, induce angiogenesis, and reduce infarct size in rats with acute myocardial infarction. Stem Cells 2008, 26:638-645.
18. Toma C., Pittenger M.F., Cahill K.S., Byrne B.J., Kessler P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2005, 105:93-98.
19. Wang C.C., Chen C.H., Hwang S.M., Lin W.W., Huang C.H., Lee W.Y., et al. Spherically symmetric mesenchymal stromal cell bodies inherent with endogenous extracellular matrices for cellular cardiomyoplasty. Stem Cells 2009, 27:724-732.
20. du Toit D., Muller C., Page B., Louw J. Foetal rat pancreatic transplantation: posttransplantation development of foetal pancreatic iso- and allografts and suppression of rejection with mycophenolate mofetil (MMF) and cyclosporine based immunesuppression. Microsc Res Tech 1998, 43:347-355.
21. Chiavegato A., Bollini S., Pozzobon M., Callegari A., Gasparotto L., Taiani J., et al. Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat. J Mol Cell Cardiol 2007, 42:746-759.
22. Lee E.J., Lee H.N., Kang H.J., Kim K.H., Hur J., Cho H.J., et al. Novel embryoid body-based method to derive mesenchymal stem cells from human embryonic stem cells. Tissue Eng Part A 2010, 16:705-715.
23. Okada M., Payne T.R., Zheng B., Oshima H., Momoi N., Tobita K., et al. Myogenic endothelial cells purified from human skeletal muscle improve cardiac function after transplantation into infarcted myocardium. J Am Coll Cardiol 2008, 52:1869-1880.
24. van der Bogt K.E., Sheikh A.Y., Schrepfer S., Hoyt G., Cao F., Ransohoff K.J., et al. Comparison of different adult stem cell types for treatment of myocardial ischemia. Circulation 2008, 118:S121-S129.
25. Tan M.Y., Zhi W., Wei R.Q., Huang Y.C., Zhou K.P., Tan B., et al. Repair of infarcted myocardium using mesenchymal stem cell seeded small intestinal submucosa in rabbits. Biomaterials 2009, 30:3234-3240.
26. Suzuki K., Murtuza B., Beauchamp J.R., Smolenski R.T., Varela-Carver A., Fukushima S., et al. Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB J 2004, 18:1153-1155.
27. Sottile J., Hocking D.C., Swiatek P.J. Fibronectin matrix assembly enhances adhesion-dependent cell growth. J Cell Sci 1998, 111:2933-2943.
28. Roubelakis M.G., Pappa K.I., Bitsika V., Zagoura D., Vlahou A., Papadaki H.A., et al. Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. Stem Cells Dev 2007, 16:931-952.
29. Haque A., Morris E.R. Thermogelatin of methylcellulose. Part I: molecular-structures and processes. Carbohyd Polym 1993, 22:161-173.
30. Haque A., Richardson R.K., Morris E.R. Thermogelatin of methylcellulose. Part II: effect of hydroxypropyl substituents. Carbohyd Polym 1993, 22:175-186.
31. Li L., Shan H., Yue C.Y., Lam Y.C., Tam K.C., Hu X. Thermally induced association and dissociation of methylcellulose in aqueous solutions. Langmuir 2002, 18:7291-7298.
32. Xu Y., Li L., Zheng P., Lam Y.C., Hu X. Controllable gelation of methylcellulose by a salt mixture. Langmuir 2004, 20:6134-6138.
33. Wang C.C., Chen C.H., Lin W.W., Hwang S.M., Hsieh P.C., Lai P.H., et al. Direct intramyocardial injection of mesenchymal-stem-cell sheet fragments improves cardiac functions after infarction. Cardiovasc Res 2008, 77:515-524.
34. Terrovitis J.V., Smith R.R., Marbán E. Assessment and optimization of cell engraftment after transplantation into the heart. Circ Res 2010, 106:479-494.
35. Laflamme M.A., Gold J., Xu C., Hassanipour M., Rosler E., Police S., et al. Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol 2005, 167:663-671.
36. Huang N.F., Yu J., Sievers R., Li S., Lee R.J. Injectable biopolymers enhance angiogenesis after myocardial infarction. Tissue Eng 2005, 11:1860-1866.
37. Dai W., Wold L.E., Dow J.S., Kloner R.A. Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction. J Am Coll Cardiol 2005, 46:714-719.
38. Singla D.K., Lyons G.E., Kamp T.J. Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling. Am J Physiol Heart Circ Physiol 2007, 293:H1308-H1314.